Despite their benefits in the treatment of cardiovascular disease, ß-blockers are seldom used to treat asthmatics. We assessed the safety and tolerability of acute dosing with esmolol and propranolol in patients with asthma.
Short, P. M., Anderson, W. J., Williamson, P. A., & Lipworth, B. J. (2014). Effects of intravenous and oral β-blockade in persistent asthmatics controlled on inhaled corticosteroids. Heart (British Cardiac Society), 100(3), 219-223. https://doi.org/10.1136/heartjnl-2013-304769